World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
42
Citations
10993
World Ranking
4870
National Ranking
107

Marek Fischer publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Marek Fischer sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 70 publications — 1st percentile

1% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Marek Fischer D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Marek Fischer sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 42 D-Index — 1st percentile

1% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Marek Fischer is affiliated with the University of Zurich in Switzerland. Their professional activities are primarily linked to this institution, where they contribute to academic research and scholarship.

There is no available information regarding recent papers authored by Marek Fischer, and no data exists about frequent co-authors or publication venues associated with their work. Additionally, there are no records of book publications or specific fields or subfields of study attributed to their academic output. Similarly, no details about main topics of their research or awards received are present.

As the provided data does not include specifics on publications or research topics, a detailed overview of their scientific contributions cannot be constructed. The profile highlights a current association with a prominent European university, indicating an active participation in an academic environment.

Best Publications

  • Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein

    Hansruedi Büeler;Marek Fischer;Yolande Lang;Yolande Lang;Horst Bluethmann;Horst Bluethmann

  • Normal host prion protein necessary for scrapie-induced neurotoxicity

    Sebastian Brandner;Stefan Isenmann;Alex Raeber;Marek Fischer

  • Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies

    Alexandra Trkola;Herbert Kuster;Peter Rusert;Beda Joos

  • HIV rebounds from latently infected cells, rather than from continuing low-level replication.

    Beda Joos;Marek Fischer;Herbert Kuster;Satish K. Pillai

  • Normal host prion protein (PrPC) is required for scrapie spread within the central nervous system

    Sebastian Brandner;Alex Raeber;Andreas Sailer;Andreas Sailer;Thomas Blättler

  • Differences in HIV Burden and Immune Activation within the Gut of HIV-Positive Patients Receiving Suppressive Antiretroviral Therapy

    Steven A. Yukl;Steven A. Yukl;Sara Gianella;Sara Gianella;Elizabeth Sinclair;Lorrie Epling

  • Heterogeneous clearance rates of long-lived lymphocytes infected with HIV: Intrinsic stability predicts lifelong persistence

    M. C. Strain;H. F. Günthard;D. V. Havlir;C. C. Ignacio

  • Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection

    Annette Oxenius;David A. Price;Huldrych F. Günthard;Sara J. Dawson

  • Effect of raltegravir-containing intensification on HIV burden and T-cell activation in multiple gut sites of HIV-positive adults on suppressive antiretroviral therapy

    Steven Yukl;Amandeep Shergill;Kenneth McQuaid;Sara Gianella

  • A Randomized Trial of Simplified Maintenance Therapy with Abacavir, Lamivudine, and Zidovudine in Human Immunodeficiency Virus Infection

    Milos Opravil;Bernard Hirschel;Adriano Lazzarin;Hansjakob Furrer

  • Emergence of minor populations of human immunodeficiency virus type 1 carrying the M184V and L90M mutations in subjects undergoing structured treatment interruptions

    Karin J. Metzner;Karin J. Metzner;Sebastian Bonhoeffer;Marek Fischer;Rose Karanicolas

  • RANTES (CCL5) uses the proteoglycan CD44 as an auxiliary receptor to mediate cellular activation signals and HIV-1 enhancement

    Branka Roscic-Mrkic;Marek Fischer;Christine Leemann;Amapola Manrique

  • Complement lysis activity in autologous plasma is associated with lower viral loads during the acute phase of HIV-1 infection.

    Michael Huber;Marek Fischer;Benjamin Misselwitz;Amapola Manrique

  • Ectopic expression of prion protein (PrP) in T lymphocytes or hepatocytes of PrP knockout mice is insufficient to sustain prion replication

    Alex J. Raeber;Andreas Sailer;Ivan Hegyi;Michael A. Klein

  • In Vivo and In Vitro Escape from Neutralizing Antibodies 2G12, 2F5, and 4E10

    Amapola Manrique;Peter Rusert;Beda Joos;Marek Fischer

  • Profound Depletion of HIV-1 Transcription in Patients Initiating Antiretroviral Therapy during Acute Infection

    Adrian Schmid;Sara Gianella;Viktor von Wyl;Karin J. Metzner

  • Quantification of infectious HIV-1 plasma viral load using a boosted in vitro infection protocol.

    Peter Rusert;Marek Fischer;Beda Joos;Christine Leemann

  • Effect of early antiretroviral therapy during primary HIV-1 infection on cell-associated HIV-1 DNA and plasma HIV-1 RNA.

    Sara Gianella;Viktor von Wyl;Marek Fischer;Barbara Niederoest

  • HIV RNA in plasma rebounds within days during structured treatment interruptions.

    Marek Fischer;Roland Hafner;Christine Schneider;Alexandra Trkola

  • Virus isolates during acute and chronic human immunodeficiency virus type 1 infection show distinct patterns of sensitivity to entry inhibitors.

    Peter Rusert;Herbert Kuster;Beda Joos;Benjamin Misselwitz

  • Productive Human Immunodeficiency Virus Type 1 Infection in Peripheral Blood Predominantly Takes Place in CD4/CD8 Double-Negative T Lymphocytes

    Philipp Kaiser;Beda Joos;Barbara Niederöst;Rainer Weber

Frequent Co-Authors

Huldrych F. Günthard
Huldrych F. Günthard University of Zurich
Rainer Weber
Rainer Weber University of Zurich
Charles Weissmann
Charles Weissmann University of Florida
Alexandra Trkola
Alexandra Trkola University of Zurich
Milos Opravil
Milos Opravil University of Zurich
Michel Aguet
Michel Aguet École Polytechnique Fédérale de Lausanne
Adriano Aguzzi
Adriano Aguzzi University of Zurich
Bernard Hirschel
Bernard Hirschel University of Geneva
Sara Gianella
Sara Gianella University of California, San Diego

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in studying Immunology in the USA, exploring related healthcare degrees online can open various career pathways. Programs like the best pmhnp programs online offer strong clinical placement opportunities, preparing students for specialized roles in psychiatric mental health nursing.

Affordability is a key consideration, and many students find value in affordable pmhnp programs that balance cost and quality education, helping them enter the healthcare field without excessive debt.

Career advancement often involves earning a Doctorate of Nursing Practice (DNP), with salaries varying by location. To get a better understanding, it’s helpful to review the doctorate in nursing salary data to find where these advanced degrees can be most lucrative.

Additionally, transitioning within nursing specialties—such as moving from a Family Nurse Practitioner (FNP) to an Acute Care Nurse Practitioner—can be achieved through targeted educational programs. Learn more about these options through resources like acute care nurse practitioner programs.

Best Scientists Citing Marek Fischer

Recently Published Articles